{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:28:15Z","timestamp":1783664895150,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic disseminated candidiasis (CDC) classically occurs after profound and prolonged neutropenia. The aim of the CANHPARI study was to assess the clinical value of adding <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose PET\/CT to conventional radiology for initial and subsequent evaluations of CDC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A pilot prospective study was conducted in 23 French onco-hematological centers from 2013 to 2017 (NCT01916057). Patients \u2265 18 y.o. suspected for CDC on abdominal conventional imaging (CT or MRI) were included. PET\/CT and conventional imaging were performed at baseline and month 3 (M3). Follow-up was assessed until M12. The primary outcome measure was the global response at M3, i.e., apyrexia and complete response to PET\/CT. The secondary outcome measure consists in comparison between responses to PET\/CT and conventional imaging at diagnosis and M3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 52 included patients, 44 were evaluable (20 probable and 24 possible CDC); 86% had acute leukemia, 55% were male (median age 47 years). At diagnosis, 34% had fever and conventional imaging was always abnormal with microabscesses on liver and spleen in 66%, liver in 25%, spleen in 9%. Baseline PET\/CT showed metabolic uptake on liver and\/or spleen in 84% but did not match with lesion localizations on conventional imaging in 32%. M3 PET\/CT showed no metabolic uptake in 13 (34%) patients, 11 still having pathological conventional imaging. Global response at M3 was observed in eight patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Baseline PET\/CT does not replace conventional imaging for initial staging of CDC lesions but should be performed after 3 months of antifungal therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p>[<jats:ext-link>www.clinicaltrials.gov<\/jats:ext-link>], identifier [NCT01916057].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1026067","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:53:25Z","timestamp":1671515605000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Does 18F-FDG PET\/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?"],"prefix":"10.3389","volume":"9","author":[{"given":"Blandine","family":"Rammaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Maunoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tioka","family":"Rabeony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Correas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Elie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Alfandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prissile","family":"Bakouboula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Candon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Montravers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis.","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4260-4","article-title":"Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies.","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.medmal.2017.12.004","article-title":"Chronic disseminated candidiasis and acute leukemia: impact on survival and hematopoietic stem cell transplantation agenda.","volume":"48","author":"Grateau","year":"2018","journal-title":"Med Mal Infect."},{"key":"B4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/mmy\/myx110","article-title":"Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.","volume":"56","author":"Jang","year":"2018","journal-title":"Med Mycol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1111\/j.1469-0691.2012.03819.x","article-title":"Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.","volume":"18","author":"De Castro","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis.","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.3390\/jof4040139","article-title":"Understanding pathogenesis and care challenges of immune reconstitution inflammatory syndrome in fungal infections.","volume":"4","author":"Delli\u00e8re","year":"2018","journal-title":"J Fungi."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/infdis\/jiz688","article-title":"Chronic disseminated candidiasis during hematological malignancies: an immune reconstitution inflammatory syndrome with expansion of pathogen-specific T helper type 1 cells.","volume":"221","author":"Candon","year":"2020","journal-title":"J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3109\/10428194.2012.677533","article-title":"Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia.","volume":"53","author":"Koh","year":"2012","journal-title":"Leuk Lymphoma."},{"key":"B12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13693780701639546","article-title":"The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections.","volume":"46","author":"Chamilos","year":"2008","journal-title":"Med Mycol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejrad.2017.02.008","article-title":"18F-FDG PET\/CT and contrast-enhanced CT findings of pulmonary cryptococcosis.","volume":"89","author":"Wang","year":"2017","journal-title":"Eur J Radiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/tid.12619","article-title":"Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.","volume":"18","author":"Mohan","year":"2016","journal-title":"Transpl Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00408-014-9589-2","article-title":"Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.","volume":"192","author":"Reyes","year":"2014","journal-title":"Lung."},{"key":"B16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.","volume":"17","author":"Hot","year":"2011","journal-title":"Clin Microbiol Infect."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12637","article-title":"Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: a case report.","volume":"19","author":"Rammaert","year":"2017","journal-title":"Transpl Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/RLU.0b013e3181a7cfba","article-title":"Hepatosplenic candidiasis imaged with F-18 FDG PET\/CT.","volume":"34","author":"Teyton","year":"2009","journal-title":"Clin Nucl Med."},{"key":"B19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.medmal.2014.03.008","article-title":"[Contribution of PET\/CT for the management of hepatosplenic candidiasis in hematology].","volume":"44","author":"Jennane","year":"2014","journal-title":"Med Mal Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7508\/aojnmb.2016.02.007","article-title":"Hepatosplenic candidiasis detected by (18)F-FDG-PET\/CT.","volume":"4","author":"Albano","year":"2016","journal-title":"Asia Ocean J Nucl Med Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/RLU.0b013e3181e4db84","article-title":"Utility of FDG PET\/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis.","volume":"35","author":"Xu","year":"2010","journal-title":"Clin Nucl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"\/CT: EANM procedure guidelines for tumour imaging: version 2.0.","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and european organization for research and treatment of cancer consensus criteria.","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med."},{"key":"B27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update.","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1600-0609.1996.tb00300.x","article-title":"Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia.","volume":"56","author":"Anttila","year":"1996","journal-title":"Eur J Haematol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","article-title":"Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis.","volume":"138","author":"Swart","year":"2018","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2967\/jnumed.109.074294","article-title":"Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET\/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.","volume":"51","author":"Rabkin","year":"2010","journal-title":"J Nucl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00259-011-1967-x","article-title":"The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.","volume":"39","author":"Fuchs","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12149-019-01358-5","article-title":"Diagnostic performance of 18F-FDG PET-CT for large vessel involvement assessment in patients with suspected giant cell arteritis and negative temporal artery biopsy.","volume":"33","author":"Hay","year":"2019","journal-title":"Ann Nucl Med."},{"key":"B35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2019.06.050","article-title":"Prognostic value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in infective endocarditis.","volume":"74","author":"San","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1007\/s00330-018-5469-0","article-title":"Diagnostic accuracy of CE-CT, MRI and FDG PET\/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and\/or local ablation.","volume":"28","author":"Sivesgaard","year":"2018","journal-title":"Eur Radiol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-016-0914-y","article-title":"A comparison of the diagnostic value of MRI and 18F-FDG-PET\/CT in suspected spondylodiscitis.","volume":"45","author":"Smids","year":"2017","journal-title":"Infection."},{"key":"B38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(91)90005-I","article-title":"Hepatosplenic candidiasis: successful treatment with fluconazole.","volume":"91","author":"Kauffman","year":"1991","journal-title":"Am J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0002-9343(91)90006-j","article-title":"Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.","volume":"91","author":"Anaissie","year":"1991","journal-title":"Am J Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis.","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/myc.13002","article-title":"Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies.","volume":"63","author":"Madney","year":"2020","journal-title":"Mycoses."},{"key":"B42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/INF.0000000000001844","article-title":"Response of symptomatic persistent chronic disseminated candidiasis to corticosteroid therapy in immunosuppressed pediatric patients: case study and review of the literature.","volume":"37","author":"Shkalim-Zemer","year":"2018","journal-title":"Pediatr Infect Dis J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1080\/10428194.2019.1691198","article-title":"Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patients.","volume":"61","author":"Fox","year":"2020","journal-title":"Leuk Lymphoma."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/jac\/dks044","article-title":"Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review.","volume":"67","author":"Chaussade","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/cid\/ciy454","article-title":"Increased metabolic activity on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in human immunodeficiency virus-associated immune reconstitution inflammatory syndrome.","volume":"68","author":"Hammoud","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections.","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/qjmed\/hcy128","article-title":"18F-FDG PET\/CT for invasive fungal infection in immunocompromised patients.","volume":"111","author":"Leroy-Freschini","year":"2018","journal-title":"QJM."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/1097-0142(19951201)76:11<2357::aid-cncr2820761126>3.0.co;2-h","article-title":"Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia.","volume":"76","author":"Walsh","year":"1995","journal-title":"Cancer."},{"key":"B49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/clinids\/24.3.375","article-title":"Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications.","volume":"24","author":"Anttila","year":"1997","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1026067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:53:35Z","timestamp":1671515615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1026067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":49,"alternative-id":["10.3389\/fmed.2022.1026067"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1026067","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1026067"}}